Letter to the EditorIL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission
References (7)
- et al.
Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment
Sem Arthr Rheum
(2007) - et al.
The Schnitzler syndrome. Four new cases and review of the literature
Medicine (Baltimore)
(2001) - et al.
Urticarial pathology in Schnitzler's (hyper-IgM) syndrome
Dermatology
(1996)
Cited by (82)
Neutrophilic Urticarial Dermatosis
2024, Dermatologic ClinicsAdvances in clinical outcomes: What we have learned during the COVID-19 pandemic
2022, Journal of Allergy and Clinical ImmunologyCitation Excerpt :In 1 RCT, improvement with ruxolitinib use was limited in significance to faster improvement on lung computed tomography and recovery from lymphopenia,112 whereas a meta-analysis that included 2 additional clinical trials concluded that ruxolitinib use reduces the risk of death (relative risk, 0.33; 95% CI, 0.13-0.88; P = .0.3).110 Inhibitors of IL-1 signaling are used for treating hemophagocytic lymphohistiocytosis and macrophage activation syndrome as well as monogenic autoinflammatory disorders.113-118 Of the 3 available IL-1β antagonists, anakinra, canakinumab, and rilonacept, anakinra, which competitively inhibits the IL-1 type I receptor, has been the most extensively studied in patients with COVID-19.
Systemic autoinflammatory disease in adults
2021, Autoimmunity ReviewsCitation Excerpt :Somatic mosaicism of NLRP3 mutations in the myeloid lineage was reported in a few patients, but is unclear if these cases should rather be considered as mosaics of CAPS [99]. Increased production of IL-1β and IL-6 by lipopolysaccharide-stimulated peripheral blood mononuclear cells was reported, and suggest increased inflammasome activity [100]. The role of the paraprotein in the pathogenesis remains unclear.
Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review
2020, Seminars in Arthritis and RheumatismSchnitzler syndrome with IgG gammopathy and elevated IL-1β and IL-17 in skin biopsy
2018, Annals of Allergy, Asthma and Immunology
Supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health. H.D.K. is supported by a grant from Studiefonds Ketel 1. A.S. is supported by a ZonMW Veni grant.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.